NCT04106726 - Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea | Biotech Hunter

Enrollment

525

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

August 4, 2020

Study Completion Date

August 4, 2020

Conditions

Facial Rosacea

Interventions

DRUG

Soolantra® Ivermectin cream 1%

Apply topically to the face once daily for 84 consecutive days.

DRUG

Ivermectin cream 1%

Apply topically to the face once daily for 84 consecutive days.

DRUG

Placebo for Ivermectin cream 1%

Apply topically to the face once daily for 84 consecutive days.

Trial Locations (11)

Zydus Worldwide DMCC, Upper Saint Clair

Zydus Worldwide DMCC, Sugarloaf

Zydus Worldwide DMCC, High Point

Zydus Worldwide DMCC, Miramar

Zydus Worldwide DMCC, Miami

Zydus Worldwide DMCC, Fort Lauderdale

Zydus Worldwide DMCC, Brandon

Zydus Worldwide DMCC, Tampa

Zydus Worldwide DMCC, Saginaw

Zydus Worldwide DMCC, El Paso

Zydus Worldwide DMCC, El Paso